TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025

Company Overview - TransMedics Group, Inc. is a medical technology company focused on transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure [3] - The company is headquartered in Andover, Massachusetts, and is recognized as the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation [3] Financial Results Announcement - TransMedics will release its financial results for the second quarter of 2025 after market close on July 30, 2025 [1] - A conference call will be hosted by the management team at 4:30 p.m. ET / 1:30 p.m. PT on the same day [1] Investor Engagement - Investors can participate in the conference call by dialing (844) 676-6010 for domestic calls or (412) 634-6944 for international calls [2] - A live and archived webcast of the conference call will be available on the "Investors" section of the TransMedics website [2]